Press Release

dRPC organizes high level advocacy dialogue on routine immunization in Nigeria

1 Mins read

The development Research and Projects Center (dRPC), under the Partnership for Advocacy in Child and Family Heath, At Scale, PACFaH@Scale, is organizing a one-day high-level strategic dialogue on Advocacy and Accountability on Routine Immunization in Nigeria.

The event, which is organized in conjunction with the National Association of Community Health Practitioners of Nigeria (NACHPN) is to strengthen the accountability framework for routine immunization service delivery as national and state levels.

In a statement signed by the Communications Specialist of the project, Malam Hassan Aliyu Karofi, and made available to newsmen in Abuja, revealed that the high level meeting is an important initiative being support by the Bill and Melinda Gates Foundation as part of the continuous efforts towards attaining the objectives of the Nigeria’s strategy for Immunization and Primary Health care system strengthening, (NSIPSS) 2018 – 2028.

He added that currently, the National Association of Community Health Practitioners of Nigeria, NACHPN is taking the lead amongst PAS CSOs and professional associations in convening of PAS/ CSOs and state RI focal persons from the PAS states of Kano, Kaduna, Niger and Lagos states.

‘The reason behind the dialogue is to explore the mechanisms for Civil Society engagement; and to examine and create an understanding of the new roles and expectations for states under the NSIPSS project.’

Related posts
Press Release

Meet the 2024 Solutions Journalism Africa Mentors

1 Mins read
Since the commencement of the Solutions Journalism Africa Initiative (SJAI) in Nigeria in late 2021, newsrooms and journalists have understood the importance…
Press Release

Gavi and UNICEF welcome approval of new oral cholera vaccine

3 Mins read
Gavi, the Vaccine Alliance and UNICEF welcome the news that a new oral cholera vaccine (OCV), Euvichol-S, has now received WHO prequalification…
Press Release

Participants in Nigeria vaccinated in first-ever Phase 2 Lassa fever vaccine clinical trial, sponsored by IAVI

7 Mins read
The CEPI-funded study will evaluate the safety, tolerability, and immunogenicity of IAVI’s single dose Lassa fever vaccine candidate Key takeaways • Participants…

Leave a Reply

Your email address will not be published. Required fields are marked *